A drug manufacturing rights. The drug is a treatment for partial seizures related to epilepsy enabling patience in reducing the frequency of partial seizures when added to an existing regimen of at least one other antiepilepsy drug.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.
Request a free trial